Clinical Trials
GlycoMimetics Reports Top-line Results From Pfizers Phase 3 Clinical Trial Evaluating Rivipansel in Sickle Cell Disease
GlycoMimetics, Inc. reported that Pfizer Inc. announced that the Phase 3 Rivipansel (GMI-1070): Evaluating Safety, Efficacy and Time to Discharge (RESET) pivotal study did...
Industry Reports
Cytena GmbH Announces That It Has Been Entered into an Agreement to Be Acquired by CELLINK
The owners of Cytena GmbH have agreed to sell all Cytena shares to CELLINK AB for a purchase price of 30.25M euros. Through CELLINK’s...
Press Releases
CPhI MEA expert growing domestic manufacturing is creating new opportunities for international Pharma in the Middle East
CPhI Middle East expert Emad Shabbir, Director at EMAD Trade House, states favorable conditions and legislative regulations in Saudi Arabia are resulting in a...
IT & Data Management
Successful Customer Meet in Hyderabad Romaco in a strong position in India
A record-breaking 400 guests turned up at the Customer Meet to witness the official opening of the Romaco Sales & Service Centre in India....
Packaging & Labelling
Lufthansa Cargo clears the new CSafe RAP Temperature-Controlled Container for departure
CSafe Global, the innovation leader in active temperature-controlled container solutions for the transport of life-enhancing pharmaceuticals, is pleased to announce that Lufthansa Cargo is...
Press Releases
Clinerion partners with the Dresden International University to generate Real World Evidence from a RWD Network for the first time in an academic setting
The Master’s Program in Clinical Research (MPCR) at Dresden International University (DIU) educates clinicians, scientists and related professionals from around the world in traditional...
News
Start-up experts to address how Thai start-ups can capture a part of the multi-billion dollar medical and healthcare market at MEDICAL FAIR THAILAND 2019
The medical device market in ASEAN is predicted to be worth US$8.5 billion by 2021, and Thai entrepreneurs want to cut themselves a big...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read